Laboratory of Biotechnology and Therapeutics, Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamadaoka, Suita, Osaka 565-0871, Japan.
Vaccine. 2013 May 1;31(19):2403-15. doi: 10.1016/j.vaccine.2013.03.022. Epub 2013 Mar 21.
Transcutaneous immunization (TCI) systems that use the skin's immune function are promising needle-free, easy-to-use, and low-invasive vaccination alternative to conventional, injectable vaccination methods. To develop effective TCI systems, it is essential to establish fundamental techniques and technologies that deliver antigenic proteins to antigen-presenting cells in the epidermis and dermis while overcoming the barrier function of the stratum corneum. In this review, we provide an outline of recent trends in the development of techniques for the delivery of antigenic proteins and of the technologies used to enhance TCI systems. We also introduce basic and clinical research involving our TCI systems that incorporate several original devices.
经皮免疫(TCI)系统利用皮肤的免疫功能,为传统的注射疫苗方法提供了一种有前途的无针、易用和低侵入性的替代方案。为了开发有效的 TCI 系统,必须建立将抗原蛋白递送至表皮和真皮中的抗原呈递细胞的基本技术和技术,同时克服角质层的屏障功能。在这篇综述中,我们概述了抗原蛋白传递技术的最新发展趋势,以及用于增强 TCI 系统的技术。我们还介绍了涉及我们的 TCI 系统的基础和临床研究,该系统包含了几种原创设备。